spacer
home > epc > summer 2014 > data driven
PUBLICATIONS
European Pharmaceutical Contractor

Data Driven

EPC:What was your entry into the pharmaceutical industry?

Elizabeth Brooks: After receiving my PhD in Mathematics, I settled in as a college professor. After several unfulfilling years, I stumbled across a job advertisement for a scientist with a strong mathematical background to work within a growing health economics consulting business. I tried it, liked it, and stayed in the industry because it is so interesting and challenging, and lets me feel like I am making a contribution to improving world health.

Describe your business philosophy.

Decision Driver Analytics is built on my belief that health economics analysis can be both rigorous enough to stand up to peer review and practical enough to guide business decisions. We believe we can best serve our customers by providing comprehensive assessments of product value throughout the product lifecycle, to drive development and use decisions.

What should pharma be focusing on in the near future?

The era of big, blockbuster drugs is probably behind us – if the industry is to remain economically healthy, it is going to have to explore new ways of creating revenue and return on investment. Cognitive analytics is a way for developers and manufacturers to use data-driven insight to make economic and marketing decisions.

What do you think are the biggest barriers to successful drug and medical device product marketing?

In today’s market – in Europe, the US and the rest of the world – drug and medical device products will not be paid for and utilised if they cannot demonstrate both clinical and economic value. In particular, the US payer market is changing rapidly, and manufacturers must be able to demonstrate value for their products in the current ‘fee for service’ environment, while also having a plan to demonstrate value in the ‘pay for performance’ marketplace of the future.

How can businesses differentiate their product in such a crowded marketplace?

Developers and manufacturers that have a value-focused strategy, aimed at demonstrating both real-world clinical effectiveness and real-world cost effectiveness at product launch will have an edge in the market.

What is the most important business lesson you have learnt?

I have learned to trust my intuition. While I have always been very analytical, with time and experience I have learned that when an opportunity feels right, it usually is, and when it doesn’t feel right, it usually isn’t.

What are your goals for the next year?

With all the changes currently impacting the healthcare market, my goal – as always – is to help our clients work through development and marketing challenges with the help of data-derived insight. Having a firm understanding of a product’s value throughout its lifecycle is key to profitability and return on investment. Our goal is to provide that understanding in the most practical, usable way possible.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Prior to launching Decision Driver Analytics in 2006, Dr Elizabeth Brooks led the health economics group at PPD, managing business and strategic development for its medical communications, health economics and late-stage study services. She is a frequent speaker at industry conferences, and has published peer-reviewed articles on a variety of mathematical and health economics topics. She also holds a PhD in Mathematics from Duke University.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo awarded with the prestigious Cargo Airline of the Year 2019 prize by the global logistics industry

 Maintaining its upward trend, Turkish Cargo was granted with the ‘Cargo Airline of the Year 2019’ award, called as the Oscar of the global logistics industry, by the global air cargo sector readers of the Air Cargo News magazine.
More info >>

White Papers

Crossing the Blood Brain Barrier (BBB): Which Route to Take?

Aptar Pharma

Aptar Pharma recently hosted an expert panel/roundtable on the various approaches to treating central nervous system (CNS) diseases. This international scientific forum was held in Paris, France on December 5th, 2014. The roundtable was organized to explore and exchange views on the challenges, approaches and opportunities that exist with regard to effectively crossing the blood brain barrier (BBB) and successfully treating a host of CNS diseases.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement